Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
APA Corp (US)
F:2S3
|
US |
|
SmileDirectClub Inc
F:0WF
|
US |
|
D
|
Dollar General Corp
XMUN:7DG
|
US |
|
T
|
T-Mobile US Inc
SWB:TM5
|
US |
|
On The Beach Group PLC
LSE:OTB
|
UK |
Wall St Price Targets
SOBI Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for SOBI is 475.4 SEK with a low forecast of 311.08 SEK and a high forecast of 577.5 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SOBI's stock price target?
Price Target
475.4
SEK
According to Wall Street analysts, the average 1-year price target for SOBI is 475.4 SEK with a low forecast of 311.08 SEK and a high forecast of 577.5 SEK.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
600%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%
The compound annual growth rate for Net Income over the next 8 years is 43%.
